Knowledge Distillery

The current COVID-19 outbreak, caused by the novel SARS-CoV-2, has raised the possibility of potential neurotropic properties of this virus.

In this article the authors detect auto-Abs neutralizing 100-fold lower, more physiological, concentrations of IFN-α and/or -ω in 13.6% of 3,595…

In this study, recently published in Neurology Neuroimmunology & Neuroinflammation, the authors conducted a survey on the risk of COVID-19 in patients…

The aim of this randomised, double-blind, placebo-controlled, multicentre trial was to analyze the effects of Remdesivir in adult patients with severe…

In this study the authors analyzed COVID-19 patients of 127 centers, diagnosed between 01/2020 and 02/2021, and registered at the European…

In this prospective observational cohort study with rapid data gathering and near real-time analysis, the authors characterised the clinical features…

The objective of this parallel, double-masked, randomized, phase IIb clinical trial, was to evaluate the safety and efficacy of 2 chloroquine…

Acute disseminated encephalomyelitis (ADEM) has been reported after coronavirus disease 2019 (COVID-19). In this review, the authors systematically…

Immunosuppression and immunomodulation are valuable therapeutic approaches for managing neuroimmunological diseases. In the present COVID-19 pandemic,…

In this paper recently published in Movement Disorders, Prasad et al., surveyed the perceptions of 100 patients with Parkinson’s disease (PD) and…

This review aims to provide a clinical practice-oriented approach to SARS-CoV-2 vaccination in MS in the era of the COVID-19 pandemic.

In this paper, the authors systematically analysed lung tissue samples from 38 patients who died from COVID-19 in two hospitals in northern Italy…